BREAKING
NVIDIA (NVDA) eyes China AI chip re-entry as export licensing shifts to case-by-case review 3 days ago Qualcomm (QCOM) authorizes $20B stock repurchase program, raises quarterly dividend to $0.92 3 days ago UP Fintech Holding Limited Reports Strong 2025 Results 3 days ago FedEx (FDX) Q3 Earnings Crush Estimates: EPS of $5.25 Beats by 27% on $24B Revenue 3 days ago Cato Corporation 2025 Financial Results Summary 3 days ago GROY Posts Breakeven Q4 Earnings, Beating Estimates by 100% as Revenue Grows 34.2% YoY to $4.5M 3 days ago York Space Systems (YSS) Posts -$0.24 EPS vs. -$0.18 Est., Revenue Soars to $105.3M 3 days ago Scholastic (SCHL) Q3 Loss Narrows to $0.15/Share vs $0.36 Estimate, Revenue Misses at $329.1M 3 days ago Curis (CRIS) EPS Soars 210.8% to $1.23, But Revenue Plunges 67.1% to $1.1M 3 days ago Eton Pharmaceuticals (ETON) Q4 Revenue Surges 82.9% YoY to $21.3M, EPS Climbs 266.7% 3 days ago NVIDIA (NVDA) eyes China AI chip re-entry as export licensing shifts to case-by-case review 3 days ago Qualcomm (QCOM) authorizes $20B stock repurchase program, raises quarterly dividend to $0.92 3 days ago UP Fintech Holding Limited Reports Strong 2025 Results 3 days ago FedEx (FDX) Q3 Earnings Crush Estimates: EPS of $5.25 Beats by 27% on $24B Revenue 3 days ago Cato Corporation 2025 Financial Results Summary 3 days ago GROY Posts Breakeven Q4 Earnings, Beating Estimates by 100% as Revenue Grows 34.2% YoY to $4.5M 3 days ago York Space Systems (YSS) Posts -$0.24 EPS vs. -$0.18 Est., Revenue Soars to $105.3M 3 days ago Scholastic (SCHL) Q3 Loss Narrows to $0.15/Share vs $0.36 Estimate, Revenue Misses at $329.1M 3 days ago Curis (CRIS) EPS Soars 210.8% to $1.23, But Revenue Plunges 67.1% to $1.1M 3 days ago Eton Pharmaceuticals (ETON) Q4 Revenue Surges 82.9% YoY to $21.3M, EPS Climbs 266.7% 3 days ago
ADVERTISEMENT
Market News

InspireMD, ReWalk Robotics decline on stock offering

Two Israeli firms – InspireMD (NYSE: NSPR) and ReWalk Robotics (NASDAQ: RWLK) – saw their shares fall during the pre-market hours of Thursday on announcements of their respective stock offerings. Shares of Tel Aviv-based InspireMD plunged 30% during morning trade after the company priced its public offering of 486,957 common stock at $5 apiece. The […]

April 4, 2019 2 min read
Market News

Two Israeli firms – InspireMD (NYSE: NSPR) and ReWalk Robotics (NASDAQ: RWLK) – saw their shares fall during the pre-market hours of Thursday on announcements of their respective stock offerings. Shares of Tel Aviv-based InspireMD plunged 30% during morning trade after the company priced its public offering of 486,957 common stock at $5 apiece. The […]

Two Israeli firms – InspireMD (NYSE: NSPR) and ReWalk Robotics (NASDAQ: RWLK) – saw their shares fall during the pre-market hours of Thursday on announcements of their respective stock offerings.

Shares of Tel Aviv-based InspireMD plunged 30% during morning trade after the company priced its public offering of 486,957 common stock at $5 apiece. The company, which makes Carotid Embolic Prevention System, expects $2.4 million in net proceeds from the offering, which will close on April 8, 2019.

The company has lost 86% of its value in the trailing 52 weeks. For the year-to-date period, the stock is down 12%.

READ: LYFT AND SIX OTHER COMPANIES WENT PUBLIC IN MARCH. FULL LIST

Meanwhile, ReWalk Robotics stock slipped 3% during the pre-market hours after the prosthetics firm said it would offer about 816,914 ordinary shares at a purchase price of $5.2025 apiece in a registered direct offering.

ReWalk will also issue unregistered warrants to buy about 408,457 ordinary shares, with a term of 5.5 years and exercise price of $5.14 per ordinary share.

The company, which makes wearable robotic exoskeletons for individuals with lower limb disabilities, expects gross proceeds of approximately $4.25 million. The offering is expected to close on April 8.

The stock is down 80% in the trailing 52 weeks. For the year-to-date period, the stock is up 6.2%.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

ADVERTISEMENT